Julius Knowles serves as Executive at Keros Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Julius Knowles has executed 265 insider transactions totaling $28.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 11, 2021 involved selling 1,575 shares valued at $103.6K.
Julius Knowles currently holds 102,233 shares of Keros Therapeutics, Inc. (KROS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Julius Knowles has been a net seller of KROS stock. They have purchased $25.0K and sold $28.8M worth of shares.
Julius Knowles's most recent insider trade was on Feb 11, 2021, when they sold 1,575 shares at $65.80 per share.
Get notified when new Form 4 filings are submitted
| $65.80 |
| Discretionary |
| Feb 11, 2021 | KROS | $61.8K | Sale | 952 | $64.87 | Discretionary |
| Feb 11, 2021 | KROS | $94.8K | Sale | 1,461 | $64.87 | Discretionary |
| Feb 11, 2021 | KROS | $97.4K | Sale | 1,526 | $63.83 | Discretionary |
| Feb 11, 2021 | KROS | $149.0K | Sale | 2,335 | $63.83 | Discretionary |
| Feb 11, 2021 | KROS | $17.0K | Sale | 270 | $62.79 | Discretionary |
| Feb 11, 2021 | KROS | $26.0K | Sale | 414 | $62.79 | Discretionary |
| Apr 13, 2020 | KROS | $25.0K | Purchase | 1,191 | $20.98 | Discretionary |
| Apr 13, 2020 | KROS | $0 | Conversion | 137,308 | $N/A | Discretionary |
| Apr 13, 2020 | KROS | $0 | Conversion | 205,962 | $N/A | Discretionary |
| Apr 13, 2020 | KROS | $0 | Conversion | 67,015 | $N/A | Discretionary |
| Apr 13, 2020 | KROS | $0 | Conversion | 44,676 | $N/A | Discretionary |
| Apr 13, 2020 | KROS | $0 | Conversion | 276,459 | $N/A | Discretionary |
| Apr 13, 2020 | KROS | $0 | Conversion | 184,305 | $N/A | Discretionary |